Details of the Drug

General Information of Drug (ID: DMRZHKL)

Drug Name
REG1
Indication
Disease Entry ICD 11 Status REF
Acute coronary syndrome BA41 Phase 3 [1]
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C20H40N3O11P
Canonical SMILES
COCCOC(=O)NCCCCC(C(=O)NCCCCCCOP(=O)(O)O)NC(=O)OCCOC
InChI
InChI=1S/C20H40N3O11P/c1-30-13-15-32-19(25)22-11-7-5-9-17(23-20(26)33-16-14-31-2)18(24)21-10-6-3-4-8-12-34-35(27,28)29/h17H,3-16H2,1-2H3,(H,21,24)(H,22,25)(H,23,26)(H2,27,28,29)
InChIKey
QGVYYLZOAMMKAH-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
86278323
CAS Number
959716-28-0
UNII
AYC3D1NPYB
DrugBank ID
DB06293
TTD ID
D05ALP

References

1 ClinicalTrials.gov (NCT01848106) A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI. U.S. National Institutes of Health.